Vanguard Group’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $421K | Hold |
|
|||||
2025
Q1 | $339K | Buy |
|
|||||
2024
Q4 | $756K | Hold |
|
|||||
2024
Q3 | $686K | Buy |
|
|||||
2024
Q2 | $1.29M | Buy |
|
|||||
2024
Q1 | $1M | Buy |
|
|||||
2023
Q4 | $1.24M | Buy |
|
|||||
2023
Q3 | $1M | Buy |
|
|||||
2023
Q2 | $513K | Sell |
|
|||||
2023
Q1 | $118K | Sell |
|
|||||
2022
Q4 | $470K | Buy |
|
|||||
2022
Q3 | $651K | Sell |
|
|||||
2022
Q2 | $761K | Hold |
|
|||||
2022
Q1 | $1.01M | Sell |
|
|||||
2021
Q4 | $2.55M | Sell |
|
|||||
2021
Q3 | $4.55M | Hold |
|
|||||
2021
Q2 | $7.51M | Buy |
|
|||||
2021
Q1 | $5.71M | Buy |
|
|||||
2020
Q4 | $2.02M | Sell |
|
|||||
2020
Q3 | $2.19M | Sell |
|
|||||
2020
Q2 | $3.17M | Sell |
|
|||||
2020
Q1 | $2.93M | Sell |
|
|||||
2019
Q4 | $4.46M | Sell |
|
|||||
2019
Q3 | $7.93M | Buy |
|
|||||
2019
Q2 | $11.3M | Buy |
|
|||||
2019
Q1 | $8.09M | Buy |
|
|||||
2018
Q4 | $5.3M | Buy |
|
|||||
2018
Q3 | $3.4M | Buy |
|
|||||
2018
Q2 | $1.77M | Buy |
|
|||||
2018
Q1 | $455K | Buy |
|
|||||
2017
Q4 | $356K | Buy |
|
|||||
2017
Q3 | $246K | Buy |
|